FDA Biologics (BLA & Biosimilars)Original article
Cellular, Tissue, and Gene Therapies Advisory Committee July 30, 2026 Meeting Announcement- UPDATED INFORMATION (as of 7/16/2026) - 07/30/2026
AdComNeutral
AI Analysis
Summary
FDA's Cellular, Tissue, and Gene Therapies Advisory Committee meeting scheduled for July 30, 2026. No specific drug candidates, companies, or outcomes mentioned in the announcement.
Importance:1/10
Sentiment:
0.00
Advisory CommitteeCBERCellular TherapyTissue TherapyGene Therapy
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on July 28, 2026 11:21 AM